关于“医药”的报告
-
-
-
-
-
-
艾媒咨询|2021年中国夜间用药年度观察报告
本报告涉及的案例/品牌/企业：美团买药，叮当快药
在众多社会服务中，夜间用药成为人们最关注的夜间社会服务之一，近年来，各地相关行政管理机构也陆续出台相关扶持政策，鼓励商家上线夜间送药平台、发展24小时药店，提供夜间送药服务，推动解决“夜间买药难”问题。近日，iiMedia Research(艾媒咨询)最新发布《2021年中国夜间用药年度观察报告》，基于2021年初至2021年末的监测数据，对中国夜间用药市场持续追踪。报告显示，年初有61.2%的用户夜间生病选择忍，而年底这一数字降至52.1%，据推算年末夜间用药受益群体新增约4000万人。报告指出，日渐成熟的中国外卖送药平台，成为解决夜间用药的重要参与者。通过一年的发展，在美团买药“小黄灯”计划等24小时药店惠民工程的推动下，线上24小时药店数量增加、夜间买药配送速度更快、服务保障更加成熟，用户知晓度有了较大提升，夜间买药难的问题得到有效缓解。
Among many social services，night medication has become one of the night social services that people pay most attention to. In recent years，relevant administrative agencies around the country have also successively issued relevant support policies to encourage businesses to launch night medication delivery platforms，develop 24-hour pharmacies，provide night medication delivery services， and promote the solution of the problem of "difficulty in buying drugs at night". Recently， iiMedia Research released the annual observation report on nighttime medication in China in 2021，which continuously tracks China's nighttime medication market based on the monitoring data from the beginning of 2021 to the end of 2021. The report shows that at the beginning of the year， 61.2% of users chose to tolerate illness at night，while at the end of the year，the figure fell to 52.1%. It is estimated that about 40 million people will benefit from night medication at the end of the year.The report points out that the increasingly mature Chinese takeout delivery platform has become an important participant in solving the problem of night medication. Through one year's development，driven by the 24-hour pharmacy benefit project such as the "small yellow light" plan of meituan drug purchase， the number of online 24-hour pharmacies has increased，the speed of drug purchase and distribution at night is faster，the service guarantee is more mature，the user awareness has been greatly improved，and the problem of difficult drug purchase at night has been effectively alleviated. -
艾媒咨询｜2022年中国幽门螺旋杆菌检测市场专题调查报告
美国将幽门螺杆菌被列为明确致癌物后，幽门螺杆菌在中国受到了极大的关注。iiMedia Research（艾媒咨询）数据显示，2021年中国幽门螺杆菌检测市场规模73.1亿元，预计2022年将达到86.6亿元。艾媒咨询分析师认为，随着大众的健康意识逐渐加强，幽门螺杆菌自测产品将成为必需品，幽门螺杆菌检测市场发展空间广阔。而幽门螺杆菌自测产品的上市，有助于推动居家检测。(《艾媒咨询｜2022年中国幽门螺旋杆菌检测市场专题调查报告》完整高清PDF版共23页，可点击文章底部报告下载按钮进行报告下载)
After the United States Department of Health & Human Services listed Helicobacter pylori as a definitive carcinogen, Helicobacter pylori received great attention in China. According to data from iiMedia Research, the market size of Helicobacter pylori testing in China will be 7.31 billion yuan in 2021 and is expected to reach 8.66 billion yuan in 2022. With increasing health awareness, Helicobacter pylori self-test product is necessary for people. The market for Helicobacter pylori self-test product is vast. The launch of Helicobacter pylori self-test products helps to promote home testing.（“iiMedia Report ｜Investigation Report on The Market of Helicobacter Pylori Testing in China in 2022”full version has 23 pages, please click the Browse HD Report button on the right side of the article to browse the report） -
艾媒咨询|2020H1中国冷链物流产业应用及典型案例研究报告
本报告研究涉及企业/品牌/案例：京东物流、海容冷链、冰山冷热、苏宁冷链。
在居民生活品质意识加强及物流产业发展日渐成熟的推动下，中国冷链物流市场规模不断扩大，2019年冷链物流市场规模已达3780亿元，并预计在2020年达到4850亿元。同时，中国冷链物流企业数量持续增长，在2019年达到了1832家，但存在着地域分布不均的问题，32.3%的企业集中在华东地区。目前冷链物流产业主要应用于食品及医药两大产品线。iiMedia Research(艾媒咨询)数据显示，2020年中国生鲜电商交易规模超过2600亿元，而医药物流市场预计在2020年达到3.8万亿元，并且预计未来冷链物流产业将开拓出新的产品线，冷链物流市场潜力较大。面对“新冠疫情”居家隔离政策下爆发的配送需求，冷链物流企业通过扩大运输网络及车辆仓储资源，同时深化信息技术的应用提高配送效能及服务体验。
Driven by people’s increasing awareness of living standard along with the development of logistics industry, the scale of China cold chain logistics market has enlarged continually, which has reached 378 billion RMB in 2019, and is expected to reach 485 billion RMB in 2020. At the same time, the number of cold chain logistics enterprises in China has increased constantly, which has reached the number of 1832 in 2019. However, there is a problem of uneven distribution, as 32.3% of the enterprises are located in the Eastern China. So far, there are two main product lines for the application of cold chain logistics, which are food and pharmaceuticals. As the data of iiMedia Research showed, the scale of China fresh food e-commerce market transaction is expected to be over 260 billion RMB, while the market scale of China pharmaceutical logistics is expected to be 3800 billion RMB in 2020, and other new product lines are also expected to be explored in the future, so the market potential of cold chain logistics is substantial. To face with the demand exposure of delivery under the policy of stay home quarantine within the “COVID-19” period, the cold chain logistics enterprises improved their delivery efficiency and customers’ service experience by expanding their delivery network, increasing the vehicles and storage resources, as well as further the application of information technology. -
艾媒咨询|2021年中国互联网医院行业发展研究报告
本报告涉及的案例/品牌/企业：医联，京东健康，好大夫
随着《健康中国2030规划纲要》、“互联网+医疗健康”的国家倡导和执行方针落实，中国互联网医院的数量在2015-2020年五年间增长近1000家，2021年进入稳定上升期。iMedia Research(艾媒咨询)数据显示，自2018年起，中国互联网医院行业进入以医院主导的互联网医院占多数的发展状态。医院主导和企业主导的互联网医院各有不同竞争优势，面对国家的规范政策和市场需求增长，通过差异化定位和院企合作能有效提升各方效益。
With the implementation of the national plan for health China 2030 and Internet plus medical health, the number of China's Internet hospitals increased by nearly 1000 in 2015-2020 years and five years, and entered a stable rise in 2021. According to the data of imedia research, since 2018, China's Internet hospital industry has entered a development state in which hospital led Internet hospitals account for the majority. Hospital led and enterprise led Internet hospitals have different competitive advantages. In the face of national normative policies and market demand growth, the benefits of all parties can be effectively improved through differentiated positioning and hospital enterprise cooperation.
- 1
- 2
- 3
- 4
- 5
- 6
- 26
